Combining perfusion and angiography with a low-dose cardiac CT technique: a preliminary investigation in a swine model

Low-dose quantitative CT myocardial flow measurement using a single volume scan: phantom and animal validation

Purpose

To validate a low-dose, single-volume quantitative CT myocardial flow technique in a cardiovascular flow phantom and a swine animal model of coronary artery disease.

Approach

A cardiovascular flow phantom was imaged dynamically over different flow rates (0.97 to 2.45    mL / min / g ) using 15 mL of contrast per injection. Six swine (37 ± 8    kg ) were also imaged dynamically, with different left anterior descending coronary artery balloon stenoses assessed under intracoronary adenosine stress, using 1    mL / kg of contrast per injection. The resulting images were used to simulate dynamic bolus tracking and peak volume scan acquisition. After which, first-pass single-compartment modeling was performed to derive quantitative flow, where the pre-contrast myocardial attenuation was assumed to be spatially uniform. The accuracy of CT flow was then assessed versus ultrasound and microsphere flow in the phantom and animal models, respectively, using regression analysis.

Results

Single-volume quantitative CT flow measurements in the phantom (Q CT _ PHANTOM ) were related to reference ultrasound flow measurements (Q US ) by Q CT _ PHANTOM = 1.04 Q US - 0.1 (Pearson's r = 0.98 ; RMSE = 0.09    mL / min / g ). In the animal model (Q CT _ ANIMAL ), they were related to reference microsphere flow measurements (Q MICRO ) by Q CT _ ANIMAL = 1.00 Q MICRO - 0.05 (Pearson's r = 0.96 ; RMSE = 0.48    mL / min / g ). The effective dose per CT measurement was 1.21 mSv.

Conclusions

The single-volume quantitative CT flow technique only requires bolus tracking data, spatially uniform pre-contrast myocardial attenuation, and a single volume scan acquired near the peak aortic enhancement for accurate, low-dose, myocardial flow measurement (in mL/min/g) under rest and adenosine stress conditions.

Dynamic CT myocardial perfusion without image registration

The aim of this study was to validate a motion-immune (MI) solution to dynamic CT myocardial perfusion measurement, in the presence of motion without image registration. The MI perfusion technique was retrospectively validated in six swine (37.3 ± 7.5 kg) with a motion-susceptible (MS) perfusion technique performed for comparison. In each swine, varying severities of stenoses were generated in the left anterior descending (LAD) coronary artery using a balloon under intracoronary adenosine stress, followed by contrast-enhanced imaging with 20 consecutive volume scans per stenosis. Two volume scans were then systematically selected from each acquisition for both MI and MS perfusion measurement, where the resulting LAD and left circumflex (LCx) measurements were compared to reference microsphere perfusion measurements using regression and diagnostic performance analysis. The MI (P_MI) and microsphere (P_MICRO) perfusion measurements were related through regression by P_MI = 0.98 P_MICRO + 0.03 (r = 0.97), while the MS (P_MS) and microsphere (P_MICRO) perfusion measurements were related by P_MS = 0.62 P_MICRO + 0.15 (r = 0.89). The accuracy of the MI and MS techniques in detecting functionally significant stenosis was 93% and 84%, respectively. The motion-immune (MI) perfusion technique provides accurate myocardial perfusion measurement in the presence of motion without image registration.

Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the Week

Coronary microvascular dysfunction is a highly prevalent condition of both structural and functional coronary disorders in patients with angina and nonobstructive coronary artery disease (ANOCA). Current diagnostic modalities to assess microvascular function are related to prognosis, but these modalities have several technical shortcomings and lack the opportunity to determine true coronary blood flow and microvascular resistance. Intracoronary continuous thermodilution assessment of absolute coronary flow (Q) and microvascular resistance (R) was recently shown to be safe and feasible in ANOCA. Further exploration and implementation could lead to a better understanding and treatment of patients with ANOCA. This review discuss the coronary pathophysiology of microvascular dysfunction, provides an overview of noninvasive and invasive diagnostics, and focuses on the novel continuous thermodilution method. Finally, how these measurements of absolute Q and R could be integrated and how this would affect future clinical care are discussed.